Ake Pousette

Author PubWeight™ 10.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Androgen induction of prostate cancer cell invasion is mediated by ezrin. J Biol Chem 2006 1.12
2 Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer -- Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scand J Urol Nephrol 2002 1.10
3 [Swedish Andrological Society apropos the criticism of the testosterone campaign: men have righteous expectations for health care within andrology]. Lakartidningen 2012 1.07
4 Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. Endocrinology 2002 0.96
5 Expression of ezrin in prostatic intraepithelial neoplasia. Urology 2004 0.94
6 Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer. Prostate 2006 0.86
7 Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer. Oncol Rep 2004 0.84
8 Androgen-independent effects of Serenoa repens extract (Prostasan®) on prostatic epithelial cell proliferation and inflammation. Phytother Res 2011 0.80
9 Left-sided grade 3 varicocele may affect the biological function of the epididymis. Scand J Urol 2013 0.77
10 Estrogens affect endothelin-1 mRNA expression in LNCaP human prostate carcinoma cells. Eur Urol 2002 0.77
11 Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy. Prostate 2006 0.77
12 Changes in tissue prostatic acidic phosphatase during endocrine treatment of patients with prostatic carcinoma. Scand J Urol Nephrol 2005 0.77
13 [Swedish Andrological Society on testosterone: misunderstood, mythical and a part of men's health]. Lakartidningen 2012 0.75